Beta interferons for multiple sclerosis.
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D055502:Secondary Prevention
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a